Home Cart Sign in  
Chemical Structure| 1801344-14-8 Chemical Structure| 1801344-14-8

Structure of Emavusertib
CAS No.: 1801344-14-8

Chemical Structure| 1801344-14-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CA-4948 is a selective and orally bioavailable IRAK4 Inhibitor. It exhibited desirable ADME and PK profiles including good oral bioavailability in mice, rat, and dog and showed >90% tumor growth inhibition in relevant tumor models with excellent correlation with in vivo PD modulation.

Synonyms: CA-4948

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Emavusertib

CAS No. :1801344-14-8
Formula : C24H25N7O5
M.W : 491.50
SMILES Code : O=C(C1=COC(C2=CC(C)=NC=C2)=N1)NC3=C(N4C[C@H](O)CC4)N=C5C(OC(N6CCOCC6)=N5)=C3
Synonyms :
CA-4948
MDL No. :MFCD32693907
InChI Key :SJHNWSAWWOAWJH-MRXNPFEDSA-N
Pubchem ID :118224491

Safety of Emavusertib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Related Pathways of Emavusertib

TLR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05178342 Myelodysplastic Syndromes|Anem... More >>ia Less << PHASE2 TERMINATED 2024-07-31 Charité Berlin - Campus Benjam... More >>in Franklin, Med. Klinik m. S. H?matologie, Onkologie, Tumorimmunologie, Berlin, 12200, Germany|Carl-Thiem-Klinikum Cottbus gGmbH, 2. Med. Klinik, Cottbus, 03048, Germany|Gemeinschaftspraxis Dr. Jacobasch Dresden, H?matologie Onkologie, Dresden, 01307, Germany|Marienhospital Düsseldorf, Klinik für Onkologie und H?matologie, Palliativmedizin, Düsseldorf, 40479, Germany|ONCOSEARCH, Institut für Klinische Studien GbR, Erlangen, 91052, Germany|InVO-Institut für Versorgungsforschung in der Onkologie, Koblenz, 56068, Germany|VK & K Studien GbR, Studienzentrum, Landshut, 84036, Germany|University Leipzig, Medizinische Klinik und Poliklinik I - H?matologie und Zelltherapie, H?mostaseologie, Leipzig, 04103, Germany|Universit?tsklinikum Schleswig-Holstein, Klinik für H?matologie und Onkologie Campus Lübeck, Lübeck, 23538, Germany|Universit?tsklinikum Mainz, III. Medizinische Klinik und Poliklinik - H?matologie, Internistische Onkologie und Pneumologie, Mainz, 55131, Germany|Universit?tsklinikum Mannheim, III. Medizinische Klinik - H?matologie und Onkologie, Mannheim, 68167, Germany|Klinikum Hochsauerland GmbH, Klinik f. H?matologie, Onkologie, Palliativmedizin, Stammzelltransplantation, Meschede, 59872, Germany|Klinikum rechts der Isar der TU München III. Medizinische Klinik - H?matologie und Onkologie, München, 81675, Germany|Friedrich-Ebert-Krankenhaus GmbH, Klinik für H?matologie, Onkologie und Nephrologie, Neumünster, 24534, Germany|Rems-Murr-Kliniken gGmbH, H?matologie, Onkologie und Palliativmedizin, Winnenden, 71364, Germany Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.03mL

0.41mL

0.20mL

10.17mL

2.03mL

1.02mL

20.35mL

4.07mL

2.03mL

References

 

Historical Records

Categories